Gemcitabine and Oxaliplatin in Patients With Metastatic Breast Cancer Resistant to or Pretreated With Both Anthracyclines and Taxanes
Mario Airoldi, C. Micari(University of Turin), Luigi Cattel(University of Turin), Laura Delprino(University of Turin), Fulvia Pedani(Ospedale San Giovanni Antica Sede), Roberto Passera(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)
Cited by 17
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k